Oncology · Phase III

Top sponsors

• AstraZeneca 75 programs
• Chinese Academy of 70 programs
• HOFFMANN-LA ROCHE 68 programs
• MSD Merck Sharp 56 programs
• First People's Hospital 53 programs
• Ningbo Cancer Hospital 44 programs
• United Therapeutics Europe 43 programs
• Anaxis Pharma 37 programs
• AstraZeneca 37 programs
• Novartis India 32 programs
• George Institute for 29 programs
• Takeda 28 programs

1. Placebo

   Regeneron UK Limited

   Colorectal Neoplasms

   phase 3 · small molecule · completed

   1 trial →

2. Placebo

   HALOZYME THERAPEUTICS, INC.

   Pancreatic Ductal Carcinoma

   phase 3 · small molecule · terminated

   1 trial →

3. Placebo

   Amgen

   Breast Cancer

   phase 3 · small molecule · terminated

   1 trial →

4. Placebo

   Hoffmann-La Roche

   Non-Squamous Non-Small Cell Lung Cancer

   phase 3 · small molecule · completed

   1 trial →

5. Placebo

   Eli Lilly and Company

   Hepatocellular Carcinoma

   phase 3 · mab · completed

   1 trial →

6. Placebo matching REGN7508, REGN7508

   Lacuna Pharma Pty Ltd

   Cancer-Associated Thrombosis (CAT).

   phase 3 · small molecule · active

   1 trial →

7. Placebo, CEMIPLIMAB

   Ningbo Cancer Hospital

   Non-small cell lung cancer

   phase 3 · small molecule · active

   1 trial →

8. Placebos

   Jian Li

   Advanced Non-small Cell Lung Cancer

   phase 3 · small molecule · completed

   1 trial →

9. Ponatinib

   Takeda

   Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)

   phase 3 · small molecule · active

   1 trial →

10. Ponatinib 30 mg QD

    Takeda

    Chronic Phase Chronic Myeloid Leukemia

    phase 3 · small molecule · terminated

    1 trial →

11. Ponatinib-3001

    Takeda

    Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

    phase 3 · small molecule · active

    1 trial →

12. Prostavue

    Curium Romania S.R.L.

    Prostate cancer

    phase 3 · small molecule · active

    1 trial →

13. Puxitatug Samrotecan

    AstraZeneca

    Endometrial Cancer

    phase 3 · small molecule · active

    1 trial →

14. QL2107, PEMBROLIZUMAB

    Lacuna Pharma Pty Ltd

    Non-small cell lung cancer

    phase 3 · small molecule · active

    1 trial →

15. Quemliclustat

    Arcus Biosciences

    Metastatic Pancreatic Ductal Adenocarcinoma

    phase 3 · small molecule · active

    1 trial →

16. R2810-ONC-16113

    Lacuna Pharma Pty Ltd

    Non-small Cell Lung Cancer

    phase 3 · small molecule · active

    1 trial →

17. R2810-ONC-1624

    Lacuna Pharma Pty Ltd

    Non-small Cell Lung Cancer

    phase 3 · small molecule · active

    1 trial →

18. R2810-ONC-1788

    Lacuna Pharma Pty Ltd

    Cutaneous Squamous Cell Carcinoma (CSCC)

    phase 3 · small molecule · active

    1 trial →

19. R3767-ONC-2011

    Lacuna Pharma Pty Ltd

    Melanoma

    phase 3 · small molecule · active

    1 trial →

20. R3767-ONC-2235

    Lacuna Pharma Pty Ltd

    Advanced Non-Small Cell Lung Cancer

    phase 3 · small molecule · active

    1 trial →

21. RAMIRIS

    The George Institute

    advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junctions, who failed prior line of palliative chemotherpay

    phase 3 · small molecule · active

    1 trial →

22. RAMUCIRUMAB, ERLOTINIB

    Eli Lilly Co.

    Metastatic Non-Small Cell Lung Cancer

    phase 3 · small molecule · active

    1 trial →

23. REGN2810

    Regeneron UK Limited

    Non-small Cell Lung Cancer

    phase 3 · small molecule · completed

    1 trial →

24. REGN2810/ipi

    Regeneron UK Limited

    Non-small Cell Lung Cancer

    phase 3 · small molecule · terminated

    1 trial →

25. REGN7508

    Regeneron UK Limited

    Cancer-Associated Thrombosis (CAT)

    phase 3 · small molecule · active

    1 trial →

26. REINFORCE

    Disc Medicine

    Metastatic hormone-sensitive prostate cancer

    phase 3 · small molecule · active

    1 trial →

27. REOLYSIN

    ONCOLYTICS BIOTECH INC

    Carcinoma, Squamous Cell of the Head and Neck

    phase 3 · mab · completed

    2 trials →

28. RLY-2608-102

    Relay Therapeutics

    PIK3CA-mutant Hormone Receptor Positive, Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Locally Advanced or Metastatic Breast Cancer

    phase 3 · small molecule · active

    1 trial →

29. RMC-6236

    Revolution Medicines

    Pancreatic Cancer

    phase 3 · small molecule · active

    1 trial →

30. RMC-6236-301

    Revolution Medicines

    non-small cell lung cancer

    phase 3 · small molecule · active

    1 trial →

31. RMC-6236-302

    Revolution Medicines

    Metastatic Pancreatic Ductal Adenocarcinoma

    phase 3 · small molecule · active

    1 trial →

32. RO5541267

    Hoffmann-La Roche

    Cohort A: • Metastatic non-small cell lung carcinoma (mNSCLC) • Extensive-stage small-cell lung carcinoma (ES-SCLC) • Advanced or unresectable hepatocellular carcinoma (HCC) Cohort B: • Resected Stage IIB-IIIB (early-stage; per the UICC/AJCC staging system, 8th edition) non-small cell lung carcinoma (NSCLC)

    phase 3 · small molecule · active

    1 trial →

33. RT2019-13

    Disc Medicine

    Patients with biochemical recurrence after primary treatment of prostate cancer presenting with =<4 metastases

    phase 3 · small molecule · active

    1 trial →

34. Radiotherapy

    International Peace Maternity and Child Health Hospital

    Cervix Cancer

    phase 3 · other · completed

    1 trial →

35. Raloxifene - Usual

    Lxo Ireland Designated Activity Company

    Breast Cancer

    phase 3 · small molecule · active

    1 trial →

36. Raludotatug Deruxtecan

    Merck Sharp and Dohme

    Gastrointestinal Cancers

    phase 3 · small molecule · active

    1 trial →

37. Ramucirumab

    Eli Lilly and Company

    Urothelial Carcinoma

    phase 3 · small molecule · completed

    1 trial →

38. Realgar-Indigo naturalis formula

    The First People's Hospital of Lianyungang

    Acute Promyelocytic Leukemia

    phase 3 · small molecule · active

    1 trial →

39. Regorafenib

    United Therapeutics Europe Ltd

    Gastro-Oesophageal Cancer

    phase 3 · small molecule · active

    1 trial →

40. Regorafenib (BAY73-4506)

    Bayer HealthCare AG

    Colorectal Neoplasms

    phase 3 · small molecule · completed

    1 trial →

41. Relacorilant, 100 mg and 25 mg

    CORCEPT THERAPEUTICS INC

    Metastatic Pancreatic Ductal Adenocarcinoma

    phase 3 · small molecule · terminated

    1 trial →

42. Relugolix

    Myovant Sciences GmbH

    Prostate Cancer

    phase 3 · small molecule · completed

    1 trial →

43. Repotrectinib

    Bristol-Myers Squibb

    Carcinoma, Non-Small-Cell Lung

    phase 3 · small molecule · active

    1 trial →

44. Retifanlimab (INCMGA00012) for Squamous Carcinoma of the Anal Canal

    Incyte

    Squamous Carcinoma of the Anal Canal

    phase 3 · small molecule · active

    1 trial →

45. Revumenib

    United Therapeutics Europe Ltd

    Acute Myeloid Leukemia, Adult

    phase 3 · small molecule · active

    1 trial →

46. Revumenib

    Syndax Pharmaceuticals

    Acute Myeloid Leukemias

    phase 3 · small molecule · active

    1 trial →

47. Ribociclib

    Novartis Pharmaceuticals

    Advanced, Metastatic Breast Cancer

    phase 3 · small molecule · completed

    1 trial →

48. Ribociclib

    Novartis Pharmaceuticals

    Breast Cancer

    phase 3 · small molecule · completed

    1 trial →

Frequently asked questions